Recent Updates
Recently added Catalysts
ORGO Positive Sentiment

Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Monday, February 12, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Organogenesis Holdings Inc. announced its participation in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference, taking place in Snowbird, UT on February 13th-14th, 2024. The company will engage in one-on-one meetings on February 14th but will not deliver a formal presentation. This involvement highlights their commitment to the regenerative medicine sector and potential business opportunities. Organogenesis focuses on advanced wound care and sports medicine markets, seeking to showcase innovative solutions.
Price reaction · baseline $3.65 (2024-02-09 close) · clean, no other ORGO news in the window
day 0 close · peak
+5.2%
day 1
-3.3%
day 3
+0.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a prominent industry conference indicates company relevance.
  • Potential networking opportunities for business development during the event.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~4 mo
High dilution risk
Lead asset
Amniotic Allograft
Phase 3 · Knee Osteoarthritis

Full Press Release Details

CANTON, Mass., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference, which is being held at the Cliff Lodge in Snowbird, UT from February 13th-14th.
Management will participate in 1x1 meetings on Wednesday, February 14th. There will be no formal presentation.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care. For more information, visit www.organogenesis.com.

Frequently Asked Questions

When will Organogenesis participate in the BTIG conference?

Organogenesis will participate in the BTIG conference on February 14th, 2024.

Will there be a formal presentation by Organogenesis at the conference?

No, there will be no formal presentation during the conference.

What markets does Organogenesis focus on?

Organogenesis focuses on advanced wound care and surgical & sports medicine.

Where is the BTIG conference being held?

The BTIG conference is being held at the Cliff Lodge in Snowbird, UT.

How can I learn more about Organogenesis?

Visit Organogenesis's website at www.organogenesis.com for more information.

ShareAdd on Google
Tags: ORGO Viatris Investor Conferences Healthcare Organogenesis BTIG Snowbird MedTech regenerative medicine advanced wound care
Last updated: Feb 12, 2024

Biotech snapshot

Cash runway
$47M liquidity · $11M/mo burn
~4 mo
High dilution risk
Lead asset
Amniotic AllograftPhase 3
Knee Osteoarthritis →